Different approaches of laparoscopic anatomic hepatectomy of segment 7 for hepatocellular carcinoma: A multicenter study.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 3/4)
유사 논문P · Population 대상 환자/모집단
124 patients who underwent LAH-S7 for HCC across seven tertiary referral medical centers in China were retrospectively analyzed.
I · Intervention 중재 / 시술
LAH-S7 for HCC across seven tertiary referral medical centers in China were retrospectively analyzed
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSIONS] Following a standardized surgical procedure, LAH-S7 is demonstrated to be safe and yields favorable oncological outcomes. Surgeons performing LAH-S7 should select the appropriate surgical approach based on the anatomical characteristics and variations of G7.
[BACKGROUND] Laparoscopic anatomic hepatectomy of segment 7 (LAH-S7) is a challenging surgery.
APA
Wang XR, Zhang QF, et al. (2026). Different approaches of laparoscopic anatomic hepatectomy of segment 7 for hepatocellular carcinoma: A multicenter study.. Hepatobiliary & pancreatic diseases international : HBPD INT, 25(1), 42-51. https://doi.org/10.1016/j.hbpd.2025.10.009
MLA
Wang XR, et al.. "Different approaches of laparoscopic anatomic hepatectomy of segment 7 for hepatocellular carcinoma: A multicenter study.." Hepatobiliary & pancreatic diseases international : HBPD INT, vol. 25, no. 1, 2026, pp. 42-51.
PMID
41219024 ↗
Abstract 한글 요약
[BACKGROUND] Laparoscopic anatomic hepatectomy of segment 7 (LAH-S7) is a challenging surgery. In this study we aimed to investigate surgical and oncological outcomes of various approaches of LAH-S7 in patients with hepatocellular carcinoma (HCC). A particular focus was placed on identifying the Glissonean pedicle of segment 7 (G7) and the intersegmental plane. Given the scarcity of comprehensive reviews or comparative studies on clinical outcomes, we also sought to analyze the experiences and advantages associated with different approaches in relation to the anatomic variations of G7.
[METHODS] The clinical data of 124 patients who underwent LAH-S7 for HCC across seven tertiary referral medical centers in China were retrospectively analyzed. Three surgical approaches were categorized based on the procedures used for G7 identification: the indocyanine green (ICG) fluorescence positive staining approach (IFPA), the Glissonean approach (GA), and the hepatic vein-guided approach (HVGA). Subsequently, the postoperative short-term results and oncological outcomes of the three different approaches were compared.
[RESULTS] The distribution of surgical approaches among the patients was as follows: IFPA in 16 (12.9%), GA in 62 (50.0%), and HVGA in 46 (37.1%) patients. Complications were observed in 27 (21.8%) patients. The 1-, 3-, and 5-year overall survival (OS) rates were 99.1%, 89.2%, and 84.7%, respectively. The 1-, 3-, and 5-year recurrence-free survival (RFS) rates were 99.0%, 84.7%, and 69.3%, respectively. The OS and RFS rates were comparable across the three approaches.
[CONCLUSIONS] Following a standardized surgical procedure, LAH-S7 is demonstrated to be safe and yields favorable oncological outcomes. Surgeons performing LAH-S7 should select the appropriate surgical approach based on the anatomical characteristics and variations of G7.
[METHODS] The clinical data of 124 patients who underwent LAH-S7 for HCC across seven tertiary referral medical centers in China were retrospectively analyzed. Three surgical approaches were categorized based on the procedures used for G7 identification: the indocyanine green (ICG) fluorescence positive staining approach (IFPA), the Glissonean approach (GA), and the hepatic vein-guided approach (HVGA). Subsequently, the postoperative short-term results and oncological outcomes of the three different approaches were compared.
[RESULTS] The distribution of surgical approaches among the patients was as follows: IFPA in 16 (12.9%), GA in 62 (50.0%), and HVGA in 46 (37.1%) patients. Complications were observed in 27 (21.8%) patients. The 1-, 3-, and 5-year overall survival (OS) rates were 99.1%, 89.2%, and 84.7%, respectively. The 1-, 3-, and 5-year recurrence-free survival (RFS) rates were 99.0%, 84.7%, and 69.3%, respectively. The OS and RFS rates were comparable across the three approaches.
[CONCLUSIONS] Following a standardized surgical procedure, LAH-S7 is demonstrated to be safe and yields favorable oncological outcomes. Surgeons performing LAH-S7 should select the appropriate surgical approach based on the anatomical characteristics and variations of G7.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (1)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.